Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

83.89
+0.78000.94%
Volume:156.77K
Turnover:13.13M
Market Cap:3.52B
PE:- -
High:84.48
Open:83.42
Low:83.42
Close:83.11
52wk High:85.46
52wk Low:64.30
Shares:42.00M
Float Shares:42.00M
Volume Ratio:0.73
T/O Rate:0.37%
Dividend:1.02
Dividend Rate:1.21%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

Lobe Sciences Names David Kideckel CFO as Mirza Rahimani Shifts to VP Finance

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Bernstein Issues a Buy Rating on UnitedHealth (UNH)

TIPRANKS
·
Aug 28

PYC Therapeutics Files 2026 Corporate Governance Statement with ASX

TIPRANKS
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28

SomnoMed Tightens Insider Trading Rules With New Securities Policy

TIPRANKS
·
Aug 28

Envoy Medical Appoints Robert Potashnick Chief Accounting Officer, VP Finance

Reuters
·
Aug 28

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

UnitedHealth downgraded to Hold from Buy at Erste Group

TIPRANKS
·
Aug 27

Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55

Simply Wall St.
·
Aug 27

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Reuters
·
Aug 27

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

Biotron Posts Wider Annual Loss but Boosts Asset Backing Amid Material Uncertainty

TIPRANKS
·
Aug 27